Form 4: Ventas EVP and CFO Executes Pre-Planned Stock Sales and Option Exercises

Robert F. Probst, Executive Vice President and Chief Financial Officer of Ventas, Inc., reported the sale of common stock and the exercise of stock options totaling over $4.4 million, all conducted under a Rule 10b5-1 trading plan.

Summary

• Robert F. Probst, EVP and CFO of Ventas, Inc. (VTR), reported transactions involving the company's common stock.
• On May 21, 2025, Mr. Probst sold 36,000 shares of common stock at a weighted average price of $64.6164 per share, totaling approximately $2,326,190.40.
• Concurrently, he exercised 33,592 stock options at an exercise price of $53.79 per share.
• Immediately following the option exercise, Mr. Probst sold the 33,592 underlying shares at a weighted average price of $64.5696 per share, totaling approximately $2,170,000.00.
• All reported transactions were executed pursuant to a Rule 10b5-1 trading plan established on February 19, 2025.
• Following these transactions, Mr. Probst beneficially owns 168,364 shares of Ventas common stock directly.
• He also holds 286,465 unexercised stock options to purchase shares of Ventas Common Stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While insider selling can be a negative signal, the fact that it was conducted under a pre-arranged 10b5-1 plan mitigates concerns about discretionary selling based on negative company outlook. The transactions also represent a profitable exercise of options for the executive.

Positives

• The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned liquidity event rather than a discretionary sale based on immediate market views.
• The sale prices of $64.6164 and $64.5696 are significantly higher than the option exercise price of $53.79, indicating a profitable transaction for the insider.

Negatives

• The Executive Vice President and CFO sold a significant number of shares (69,592 shares in total), which can sometimes be perceived negatively by investors as it reduces insider ownership.

Risks

• While conducted under a 10b5-1 plan, insider selling, particularly by a key executive, can sometimes be interpreted by the market as a lack of confidence in the company's near-term prospects, potentially leading to negative share price pressure.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook. It is a report of past insider transactions.

Industry Context

This filing reports an insider transaction for Ventas, Inc., a leading healthcare real estate investment trust (REIT). While the filing itself does not provide industry-wide context, insider selling activity is a common occurrence across all industries, often for personal financial planning reasons, especially when executed under a Rule 10b5-1 plan.

Stakeholder Impact

• Shareholders: May observe a reduction in direct insider ownership, but the pre-planned nature of the transactions under a 10b5-1 plan suggests a routine financial management activity rather than a signal of lack of confidence.

Key Dates

Recommendation

Keywords

Ventas, VTR, Form 4, insider trading, stock options, executive compensation, Rule 10b5-1 plan, healthcare REIT, real estate investment trust